News & Press: Advocacy

SIS Commends NICE on Senza SCS Therapy Assessment

Monday, November 13, 2017  
Share |

On November 9, 2017, Dr. Timothy Maus, President of the Spine Intervention Society, submitted comments on the draft medical technology assessment completed by the U.K.’s National Institute for Health and Care Excellence (NICE) regarding Senza HF10 spinal cord stimulation therapy for chronic neuropathic pain.

"On behalf of the Spine Intervention Society (SIS), I would like to commend the National Institute for Health and Care Excellence (NICE) on the draft medical technology assessment of Senza's High Frequency 10kHz Spinal Cord Stimulation (HF10 SCS) to treat chronic neuropathic pain. Traditional SCS is a well-established treatment for patients with refractory chronic neuropathic pain. More recently, HF10 SCS therapy has demonstrated benefits that exceed even those of traditional SCS. The NICE assessment appropriately identifies and summarizes the evidence demonstrating the safety and effectiveness of HF10 SCS therapy and concludes that it represents an advancement in SCS programming and technology that has demonstrated superiority in controlled studies to traditional SCS, an already well-established and covered treatment.  SIS supports the recommendation that HF10 SCS therapy be a covered treatment for patients with chronic neuropathic pain."

 

NICE invites comments on the consultation document through December 4, 2017. The consultation document and supporting information can be found here on the NICE website.


Contact Us

120 E. Ogden Ave. Ste. 202
Hinsdale, Illinois 60521
P: 630.203.2252
Toll Free: 888.255.0005

© Copyright 2016 Spine Intervention Society Privacy Policy  ::  Legal